Jensen MC - Search Results

1

Biophotonic cytotoxicity assay for high-throughput screening of cytolytic killing.

Brown CE, Wright CL, Naranjo A, Vishwanath RP, Chang WC, Olivares S, Wagner JR, Bruins L, Raubitschek A, Cooper LJ, Jensen MC. Brown CE, et al. Among authors: jensen mc. J Immunol Methods. 2005 Feb;297(1-2):39-52. doi: 10.1016/j.jim.2004.11.021. Epub 2005 Jan 22. J Immunol Methods. 2005. PMID: 15777929

2

Genetic engineering of cytolytic T lymphocytes for adoptive T-cell therapy of neuroblastoma.

Gonzalez S, Naranjo A, Serrano LM, Chang WC, Wright CL, Jensen MC. Gonzalez S, et al. Among authors: jensen mc. J Gene Med. 2004 Jun;6(6):704-11. doi: 10.1002/jgm.489. J Gene Med. 2004. PMID: 15170741

3

Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells.

Kahlon KS, Brown C, Cooper LJ, Raubitschek A, Forman SJ, Jensen MC. Kahlon KS, et al. Among authors: jensen mc. Cancer Res. 2004 Dec 15;64(24):9160-6. doi: 10.1158/0008-5472.CAN-04-0454. Cancer Res. 2004. PMID: 15604287

4

A quantitative high-throughput chemotaxis assay using bioluminescent reporter cells.

Vishwanath RP, Brown CE, Wagner JR, Meechoovet HB, Naranjo A, Wright CL, Olivares S, Qian D, Cooper LJ, Jensen MC. Vishwanath RP, et al. Among authors: jensen mc. J Immunol Methods. 2005 Jul;302(1-2):78-89. doi: 10.1016/j.jim.2005.04.021. J Immunol Methods. 2005. PMID: 15987642

5

Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma.

Cooper LJ, Ausubel L, Gutierrez M, Stephan S, Shakeley R, Olivares S, Serrano LM, Burton L, Jensen MC, Forman SJ, DiGiusto DL. Cooper LJ, et al. Among authors: jensen mc. Cytotherapy. 2006;8(2):105-17. doi: 10.1080/14653240600620176. Cytotherapy. 2006. PMID: 16698684

6

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect.

Cooper LJ, Topp MS, Serrano LM, Gonzalez S, Chang WC, Naranjo A, Wright C, Popplewell L, Raubitschek A, Forman SJ, Jensen MC. Cooper LJ, et al. Among authors: jensen mc. Blood. 2003 Feb 15;101(4):1637-44. doi: 10.1182/blood-2002-07-1989. Epub 2002 Oct 10. Blood. 2003. PMID: 12393484 Free article.

7

Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1.

Cooper LJ, Al-Kadhimi Z, Serrano LM, Pfeiffer T, Olivares S, Castro A, Chang WC, Gonzalez S, Smith D, Forman SJ, Jensen MC. Cooper LJ, et al. Among authors: jensen mc. Blood. 2005 Feb 15;105(4):1622-31. doi: 10.1182/blood-2004-03-1208. Epub 2004 Oct 26. Blood. 2005. PMID: 15507526 Free article.

8

Amplification of RNAi--targeting HLA mRNAs.

Gonzalez S, Castanotto D, Li H, Olivares S, Jensen MC, Forman SJ, Rossi JJ, Cooper LJ. Gonzalez S, et al. Among authors: jensen mc. Mol Ther. 2005 May;11(5):811-8. doi: 10.1016/j.ymthe.2004.12.023. Mol Ther. 2005. PMID: 15851019 Free article.

9

T-cell genetic modification for re-directed tumor recognition.

Cooper LJ, Kalos M, DiGiusto D, Brown C, Forman SJ, Raubitschek A, Jensen MC. Cooper LJ, et al. Among authors: jensen mc. Cancer Chemother Biol Response Modif. 2005;22:293-324. doi: 10.1016/s0921-4410(04)22014-2. Cancer Chemother Biol Response Modif. 2005. PMID: 16110618 Review. No abstract available.

10

Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancy.

Singh H, Serrano LM, Pfeiffer T, Olivares S, McNamara G, Smith DD, Al-Kadhimi Z, Forman SJ, Gillies SD, Jensen MC, Colcher D, Raubitschek A, Cooper LJ. Singh H, et al. Among authors: jensen mc. Cancer Res. 2007 Mar 15;67(6):2872-80. doi: 10.1158/0008-5472.CAN-06-2283. Cancer Res. 2007. PMID: 17363611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page